Flavonoid and lignan intake and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 27184434)

Published in Int J Cancer on June 10, 2016

Authors

Esther Molina-Montes1,2, María-José Sánchez1,2, Raul Zamora-Ros3, H B As Bueno-de-Mesquita4,5,6,7, Petra A Wark8, Mireia Obon-Santacana9, Tilman Kühn10, Verena Katzke10, Ruth C Travis11, Weimin Ye12,13, Malin Sund12,13, Alessio Naccarati14, Amalia Mattiello15, Vittorio Krogh16, Caterina Martorana17, Giovanna Masala18, Pilar Amiano2,19, José-María Huerta2,20, Aurelio Barricarte2,21, José-Ramón Quirós22, Elisabete Weiderpass12,23,24,25, Lene Angell Åsli23, Guri Skeie23, Ulrika Ericson26, Emily Sonestedt26, Petra H Peeters6,27, Isabelle Romieu3, Augustin Scalbert3, Kim Overvad28, Matthias Clemens29, Heiner Boeing29, Antonia Trichopoulou30,31, Eleni Peppa30, Pavlos Vidalis30, Kay-Tee Khaw32, Nick Wareham33, Anja Olsen34, Anne Tjønneland34, Marie-Christine Boutroun-Rualt35, Françoise Clavel-Chapelon35, Amanda J Cross6, Yunxia Lu6, Elio Riboli6, Eric J Duell9

Author Affiliations

1: Andalusian School of Public Health, Instituto De Investigación Biosanitaria Ibs, GRANADA, Hospitales Universitarios De Granada/Universidad De Granada, Granada, Spain.
2: CIBERESP, CIBER Epidemiología Y Salud Pública, Spain.
3: Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon, France.
4: National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
5: Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
6: Department of Epidemiology and Biostatistics, the School of Public Health, Imperial College London, London, United Kingdom.
7: Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
8: Global eHealth Unit, Department of Primary Care and Public Health, the School of Public Health, Imperial College London, London, United Kingdom.
9: Unit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain.
10: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
11: Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
12: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
13: The Medical Biobank at Umeå University, Umeå, Sweden.
14: Molecular and Genetic Epidemiology Unit, HuGeF-Human Genetics Foundation, Torino, Italy.
15: Dipartimento Di Medicina Clinica E Chirurgia, Federico II University, Naples, Italy.
16: Epidemiology and Prevention Unit Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
17: Cancer Registry ASP, Ragusa, Italy.
18: Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy.
19: Public Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastián, Spain.
20: Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
21: Public Health Institute of Navarra, Pamplona, Spain.
22: Public Health Directorate, Asturias, Spain.
23: Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, the Arctic University of Norway, Tromsø, Norway.
24: Department of Research, Cancer Registry of Norway, Oslo, Norway.
25: Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland.
26: Department of Clinical Sciences in Malmö, Lund University, Lund, Sweden.
27: Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands.
28: Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
29: Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
30: Hellenic Health Foundation, Athens, Greece.
31: WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology, and Medical Statistics, University of Athens Medical School, Athens, Greece.
32: University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
33: Epidemiology Unit, Medical Research Council, Cambridge, United Kingdom.
34: Danish Cancer Society Research Center, Copenhagen, Denmark.
35: Inserm, CESP Centre for Research in Epidemiology and Population Health, France.

Articles cited by this

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03

European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77

The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 4.73

Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr (2002) 3.92

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology (2007) 3.60

Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed (1997) 2.36

Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford) (2010) 2.28

Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25

Validation and calibration of dietary intake measurements in the EPIC project: methodological considerations. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 2.23

The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr (2007) 2.21

Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res (2008) 1.79

Flavonols and pancreatic cancer risk: the multiethnic cohort study. Am J Epidemiol (2007) 1.69

Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol (1997) 1.56

Use of dietary supplements in the European Prospective Investigation into Cancer and Nutrition calibration study. Eur J Clin Nutr (2009) 1.49

Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem (2013) 1.27

Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr (2009) 1.24

Dietary flavonoid intake and risk of cancer in postmenopausal women: the Iowa Women's Health Study. Int J Cancer (2008) 1.24

Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol (2014) 1.20

Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control (2002) 1.20

Differences in dietary intakes, food sources and determinants of total flavonoids between Mediterranean and non-Mediterranean countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Nutr (2012) 1.17

Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr (2009) 1.11

Food intake of individuals with and without diabetes across different countries and ethnic groups. Eur J Clin Nutr (2011) 1.10

The association between dietary flavonoid and lignan intakes and incident type 2 diabetes in European populations: the EPIC-InterAct study. Diabetes Care (2013) 1.10

A food pattern that is predictive of flavonol intake and risk of pancreatic cancer. Am J Clin Nutr (2008) 1.03

Flavonoid intake and risk of pancreatic cancer in male smokers (Finland). Cancer Epidemiol Biomarkers Prev (2008) 1.01

Dietary flavonoids intake and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Clin Nutr (2013) 0.99

Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Cancer Epidemiol Biomarkers Prev (2011) 0.96

Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis. PLoS One (2013) 0.94

Intake of fruits and vegetables and risk of pancreatic cancer in a pooled analysis of 14 cohort studies. Am J Epidemiol (2012) 0.93

Phytochemicals and cancer risk: a review of the epidemiological evidence. Nutr Clin Pract (2012) 0.92

Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits. Am J Clin Nutr (2014) 0.92

Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women. Diabetes Care (2014) 0.92

Dietary factors and pancreatic cancer: the role of food bioactive compounds. Mol Nutr Food Res (2010) 0.90

Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Nutr (2015) 0.88

Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition and Cancer Study. Clin Gastroenterol Hepatol (2013) 0.88

Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Br J Cancer (2014) 0.88

Dietary catechins and epithelial cancer incidence: the Zutphen elderly study. Int J Cancer (2001) 0.85

Proanthocyanidins and other flavonoids in relation to pancreatic cancer: a case-control study in Italy. Ann Oncol (2011) 0.83

Flavonoid intake and risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study Cohort. Br J Cancer (2013) 0.82

Articles by these authors

Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet (2014) 2.39

Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer (2015) 1.82

A genome-wide pleiotropy scan for prostate cancer risk. Eur Urol (2014) 1.48

The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One (2016) 1.40

Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study. Eur J Epidemiol (2016) 1.07

Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol (2017) 1.00

Long-term exposure to elemental constituents of particulate matter and cardiovascular mortality in 19 European cohorts: results from the ESCAPE and TRANSPHORM projects. Environ Int (2014) 0.97

The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. Cancer Res (2014) 0.96

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet (2016) 0.93

Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer. PLoS Genet (2014) 0.93

Dietary cadmium intake and risk of breast, endometrial and ovarian cancer in Danish postmenopausal women: a prospective cohort study. PLoS One (2014) 0.93

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort. Clin Cancer Res (2016) 0.92

Genome-Wide Association Study of Prostate Cancer-Specific Survival. Cancer Epidemiol Biomarkers Prev (2015) 0.91

Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) study. BMJ Open (2014) 0.91

Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort. Int J Cancer (2015) 0.90

A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study. Mutagenesis (2015) 0.90

General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2015) 0.89

Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Cancer Epidemiol Biomarkers Prev (2015) 0.89

Investigation of dietary factors and endometrial cancer risk using a nutrient-wide association study approach in the EPIC and Nurses' Health Study (NHS) and NHSII. Cancer Epidemiol Biomarkers Prev (2015) 0.89

Residential exposure to traffic noise and health-related quality of life--a population-based study. PLoS One (2015) 0.89

Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies. PLoS One (2014) 0.89

Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Nutr (2015) 0.88

A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer. PLoS One (2014) 0.88

Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clin Epigenetics (2015) 0.88

Genome-wide interaction study of smoking and bladder cancer risk. Carcinogenesis (2014) 0.87

Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer (2015) 0.87

Vegetable and fruit consumption and the risk of hormone receptor-defined breast cancer in the EPIC cohort. Am J Clin Nutr (2015) 0.86

Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort. Cancer Epidemiol Biomarkers Prev (2015) 0.85

Plasma elaidic acid level as biomarker of industrial trans fatty acids and risk of weight change: report from the EPIC study. PLoS One (2015) 0.84

Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study. PLoS One (2015) 0.83

Mortality in vegetarians and comparable nonvegetarians in the United Kingdom. Am J Clin Nutr (2015) 0.83

Relationship between N-terminal pro-brain natriuretic peptide, obesity and the risk of heart failure in middle-aged German adults. PLoS One (2014) 0.83

The influence of whole grain products and red meat on intestinal microbiota composition in normal weight adults: a randomized crossover intervention trial. PLoS One (2014) 0.82

Physical Activity, Bone Health, and Obesity in Peri-/Pre- and Postmenopausal Women: Results from the EPIC-Potsdam Study. Calcif Tissue Int (2015) 0.82

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations. Cancer Res (2016) 0.82

Update of the German Diabetes Risk Score and external validation in the German MONICA/KORA study. Diabetes Res Clin Pract (2014) 0.81

Dietary Intake Estimates and Urinary Cadmium Levels in Danish Postmenopausal Women. PLoS One (2015) 0.80

What characterises women who eat potatoes? A cross-sectional study among 74,208 women in the Norwegian Women and Cancer cohort. Food Nutr Res (2015) 0.80

The improved physical activity index for measuring physical activity in EPIC Germany. PLoS One (2014) 0.80

Prolactin determinants in healthy women: A large cross-sectional study within the EPIC cohort. Cancer Epidemiol Biomarkers Prev (2014) 0.79

Reproducibility of Retinol Binding Protein 4 and Omentin-1 Measurements over a Four Months Period: A Reliability Study in a Cohort of 207 Apparently Healthy Participants. PLoS One (2015) 0.79

The association of substituting carbohydrates with total fat and different types of fatty acids with mortality and weight change among diabetes patients. Clin Nutr (2015) 0.79

A Nested Case-Control Study of Metabolically Defined Body Size Phenotypes and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). PLoS Med (2016) 0.79

Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC-Potsdam Cohort Study. Cancer Res (2016) 0.79

Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population. Urology (2016) 0.79

Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study. PLoS One (2015) 0.79

Plasma alkylresorcinol concentrations, biomarkers of whole-grain wheat and rye intake, in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Br J Nutr (2014) 0.78

Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort. Int J Cancer (2015) 0.78

Dietary intake of acrylamide and epithelial ovarian cancer risk in the european prospective investigation into cancer and nutrition (EPIC) cohort. Cancer Epidemiol Biomarkers Prev (2014) 0.78

Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study. Int J Cancer (2015) 0.78

Body iron status and gastric cancer risk in the EURGAST study. Int J Cancer (2015) 0.78

Adipose tissue trans-fatty acids and changes in body weight and waist circumference. Br J Nutr (2013) 0.78

Interaction between genetic predisposition to adiposity and dietary protein in relation to subsequent change in body weight and waist circumference. PLoS One (2014) 0.78

Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort. Cancer Epidemiol Biomarkers Prev (2016) 0.78

Prediagnostic intake of dairy products and dietary calcium and colorectal cancer survival--results from the EPIC cohort study. Cancer Epidemiol Biomarkers Prev (2014) 0.78

Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study. Diabetes Care (2016) 0.77

Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis. Int J Epidemiol (2016) 0.77

Adherence to the healthy Nordic food index, dietary composition, and lifestyle among Swedish women. Food Nutr Res (2015) 0.77

Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study. Br J Cancer (2015) 0.77

Plasma fetuin-A concentration, genetic variation in the AHSG gene and risk of colorectal cancer. Int J Cancer (2015) 0.77

Circulating Folate and Vitamin B12 and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls. Eur Urol (2016) 0.77

Associations between Recreational and Commuter Cycling, Changes in Cycling, and Type 2 Diabetes Risk: A Cohort Study of Danish Men and Women. PLoS Med (2016) 0.77

An epidemiological model for prediction of endometrial cancer risk in Europe. Eur J Epidemiol (2015) 0.77